ABSTRACT. We investigated the association between polymorphisms in the adiponectin gene (APM-1) and atherosclerotic cerebral infarction (ACI) in a Chinese Han population of Hainan Province. Polymerase chain reaction-restriction fragment length polymorphism and gene sequencing were used to analyze the distribution of APM-1 +45T/G and +276G/T genotypes and their alleles in 120 ACI patients and 120 healthy controls. No statistical correlation was found in the frequency and distribution of the genotype 45T/G between the ACI group and the control group. Genotypic frequencies of GG, GT, and TT at the APM-1 +276 locus were 70.0% (84/120), 25.0% (30/120), and 5.0% (6/120), respectively, in the ACI group, while these values were 52.5% (63/120), 37.5% (45/120), and 10.0% (12/120), respectively, in the control group. The frequency of the G allele was 82.5% (198/240) in the ACI group and 71.25% (171/240) in the control group. The T allele frequency was 17.5% (42/240) in the ACI group and 28.75% (69/240) in the control group. Polymorphisms at the APM-1 -276 locus in the case-controlled 4143 Associations between polymorphisms in APM-1 gene and ACI ©FUNPEC-RP www.funpecrp.com.br Genetics and Molecular Research 14 (2): 4142-4149 (2015) groups showed significant differences in the genotype distribution and allele frequency between the 2 groups (P = 0.041). The occurrence of ACI in the Hainan Chinese Han population may be associated with +276G/T polymorphisms but not with +45T/G polymorphisms in the APM-1 gene.
INTRODUCTION
In recent years, the age of the world population has increased. Consequently, cerebrovascular disease and other aging-related diseases have become important public health problems (Han et al., 2011) . In China, the incidence rate of atherosclerotic cerebral infarction (ACI) in the ischemic stroke population is approximately 80% and is continually increasing. Therefore, an in-depth study of the pathogenesis of ACI is urgently needed. Atherosclerosis is recognized as the main pathogenesis of ACI. Adiponectin is a fat factor that is protective in the human body. Its biological effects include anti-atherosclerosis, anti-inflammation, increasing insulin sensitivity, maintaining energy balance, and involvement in glucose and lipid metabolism. Adiponectin has been shown to be an important factor influencing the susceptibility to type 2 diabetes mellitus. Polymorphisms in the adiponectin gene APM-1 (-11377C>G, -11426A>G, +45T>G, +276G/T, -11391G>A) are related to the susceptibility of type 2 diabetes (Han et al., 2011; Kacso et al., 2012; Chu et al., 2013) . This may be because polymorphisms in the adiponectin gene alter adiponectin expression, which affects glucose and lipid metabolism. Atherosclerosis is caused by disorders in lipid and glucose metabolism. The anti-atherosclerosis property of adiponectin is mainly characterized by its effect on endothelial function, inflammation, and arterial remodeling (Motobayashi et al., 2009; Chen et al., 2010; Kyriazi et al., 2011) .
The close correlation between adiponectin and ischemic stroke has been confirmed in numerous studies (Yatomi et al., 2009; Marousi et al., 2010; Nagasawa et al., 2011) . In addition, polymorphisms in the adiponectin gene may affect adiponectin levels in the serum (Mente et al., 2013) . However, no studies have examined the role of adiponectin gene polymorphisms in ischemic stroke, particularly in ACI. Some studies have found that the adiponectin gene is related to the incidence of ischemic stroke and formation of carotid artery plaques in American men, Japanese populations, and South Korean populations. However, few studies have examined these properties in Chinese populations (Hegener et al., 2006; Kim et al., 2008; Yamada et al., 2008; Cheong et al., 2011; Mente et al., 2013) .
In this study, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to investigate the distribution of 45T/G and 276G/T genotypes and alleles of APM-1 in 120 ACI patients and 120 normal healthy controls. We examined the role of APM-1 polymorphisms in ACI in a Han population in the Hainan Province in China, as well as provide a theoretical basis for the pathogenesis of cerebral infarction.
MATERIAL AND METHODS

Subjects
Department of Neurology of the People's Hospital of Hainan Province, including 78 males and 42 females with a mean age of 58.43 ± 10.86 years and mean body mass index of 26.28 ± 2.59 kg/m 2 . All patients were diagnosed according to the revised diagnostic criteria for cerebral infarction established by the Fourth National Cerebrovascular Diseases Conference, and then confirmed by head computed tomography and/or magnetic resonance imaging. Patients with cerebral infarction caused by other diseases were excluded from this study. In addition, 120 healthy volunteers, including 60 males and 60 females with a mean age of 57.96 ± 9.52 years and mean body mass index of 23.10 ± 2.14 kg/m 2 , were enrolled as the control group in this study. Patients with stroke, coronary heart disease, kidney disease, blood disorders, autoimmune diseases, pregnancy, thrombotic disease, or having received a lipid-lowering therapy in the last 6 months were excluded from this study. All patients and the healthy controls were Hainan Chinese Han without any familial relationship. This study was conducted in accordance with the Declaration of Helsinki and with approval from the Ethics Committee of the People's Hospital of Hainan Province. Written informed consent was obtained from all participants.
Preparation of DNA samples
To prepare DNA samples, 5 mL sodium citrate anticoagulant peripheral venous blood was collected at 7:00 am to 8:00 am after the subjects were fasted for 12 h. DNA was extracted from blood samples using a conventional phenol/chloroform extraction method.
Primer design
Primers were designed using the Primer Premier 5.0 software (Premier Biosoft, Palo Alto, CA, USA) and synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). Gene sequencing was performed by Shanghai Biocolor Bioscience & Technology Company (Shanghai, China). PCR primer sequences were 5'-CTGAGATGGACGGAGTCCTTT-3' and 5'-CCAAATCACTTCAGGTTGCTT-3', with a length of the amplified sequence of 456 bp.
Gene sequencing
Genotyping was performed using PCR-RFLP combined with DNA sequencing. All enzyme-digested products were separated by 2% agarose gel electrophoresis and analyzed using a GIS gel image processing system (Tanon Science and Technology Co., Ltd., Shanghai, China).
Statistical analysis
The goodness of fit of the genotypes with Hardy-Weinberg equilibrium was tested using the HWE software. Genotype and allele frequencies were calculated by direct counting. Frequency data were analyzed using the chi-square test. Measurement data in the 2 groups were compared using the Student t-test. Comparisons between more than 2 groups were analyzed using the analysis of variance Student-Newman-Keuls method. All statistical analyses were performed using SPSS13.0 (SPSS, Inc., Chicago, IL, USA). P < 0.05 was considered to be statistically significant.
RESULTS
Distribution of APM-1 +45T/G polymorphism
PCR products were digested using endonuclease Eco88I at 37°C for 16 h. RFLP digestion products were separated by agarose gel electrophoresis (Figure 1) . APM-1 +45T/G genotype TT showed a band at 456 bp, TG showed 3 bands, 456, 313, and 1431 bp, and genotype GG showed 2 bands at 313 and 143 bp. As analyzed using the HWE software, the observed and expected numbers of the APM-1 +45T/G genotypes showed no statistical differences between the ACI group and the control group (P > 0.05), indicating that the gene frequency at the APM-1 +45T/G locus of the population in this study was in Hardy-Weinberg equilibrium (Table 1 ). 
Comparison of APM-1 +45T/G genotype frequencies between the ACI group and the control group
The frequencies of APM-1 +45T/G genotypes TT, GT, and GG were 54.17% (65/120), 33.33% (40/120), and 12.50% (15/120), respectively, in the ACI group, showing no significant differences from the control group [52.50% (63/120), 35.83% (43/120), and 11.67% (14/120), respectively]. Frequencies of the T and G alleles in the ACI group were 70.83 and 29.17%, respectively, while these values were 70.41 and 29.59%, respectively, in the control group; there was no statistically significant difference between groups (P = 0.917 for genotype frequencies, and P = 0.9202 for allele frequencies; 
Distribution of APM-1 +276G/T polymorphism
APM-1 +276G/T genotypes were obtained by enzyme digestion using BsmI and separation by agarose gel electrophoresis (Figure 2 ). Genotype TT appeared as 1 band (456 bp), genotype TG showed 3 bands (456, 374, and 82 bp), and genotype GG showed 2 bands (374 and 82 bp). The goodness of fit test using the HWE software showed that the observed and expected numbers of APM-1 +276G/T genotypes in the ACI group were not significantly different from those in the control group (P > 0.05), indicating that the gene frequency of APM-1 +276G/T genotypes were in Hardy-Weinberg equilibrium (Table 3 ). 
Comparison of APM-1 +276G/T genotype frequencies between the ACI group and the control group
Eighty-four patients (70.0%) carried the APM-1 +276G/T genotype GG, 30 patients (25.0%) carried the APM-1 +276G/T genotype GT, and 6 patients (5.0%) carried the APM-1 +276G/T genotype TT in the ACI group. In contrast, subjects with APM-1 +276G/T genotypes GG, GT, and TT accounted for 52.5% (63/120), 37.5% (45/120), and 10.0% (12/120), respectively, in the control group. G and T allele frequencies in the ACI group was 82.5% (198/240) and 17.5% (42/240), respectively. In contrast, these values were 71.25% (171/240) and 28.75% (69/240), respectively, in the control group. The frequencies of the APM-1 +276G/T genotypes and alleles were significantly different between the ACI group and the control group (P = 0.020 for genotype frequencies, and P = 0.005 for allele frequencies; Table 4 ). Table 4 . Distribution of APM-1 +276G/T genotypes and alleles (N = 120). 
DISCUSSION
Adiponectin, identified in the mid-1990s, is a specific hormone protein secreted by adipocytes that plays an important regulatory role in glucose and lipid metabolism, insulin resistance, anti-inflammatory, anti-atherosclerosis, and other biochemical processes. Thus, it is regarded as a protective factor. Adiponectin is closely related to obesity, insulin resistance, diabetes, dyslipidemia, hypertension, coronary heart disease, and other diseases (Wasim et al., 2006; Pan and Kastin, 2007; Matsumoto et al., 2008; Rabe et al., 2008; Walsh, 2009; Ong et al., 2010) .
The APM-1 gene encodes human adiponectin and is located in the chromosome 3q27 region. It contains 3 exons (exon 1 is a non-coding region, exons 2 and 3 contain the coding region and part of the non-coding regions for adiponectin), and 2 introns. Thirteen common single nucleotide polymorphisms (SNPs) have been identified in the APM-1 gene. These common SNPs affect type 2 diabetes mellitus, metabolic syndrome, and coronary heart disease in the chromosome 3q27 region. Therefore, the relationship between APM-1 SNPs on chromosome 3q27 and these diseases, particularly for the adiponectin 45 and 276 loci, have received increasing attention (Pischon et al., 2007; Foucan et al., 2010; Jing et al., 2012; Arnaiz-Villena et al., 2013; Lee et al., 2013) .
In this study, 120 patients with ACI and 120 healthy controls were examined for the APM-1 +45 SNP and APM-1 +276 SNP variants in patients with atherosclerotic cerebral infarction in the Hainan area. The APM-1 +45 genotype distribution and allele frequencies in the ACI group were not significantly different from those in the control group, suggesting that APM-1 +45 SNP is not associated with the susceptibility to cerebral infarction, which is consistent with previous studies (Jang et al., 2005; Hegener et al., 2006) . The genotype distributions at the APM-1 +276 locus were GG (N = 84), GT (N = 30), and TT (N = 6) in the ACI group and GG (N = 63), GT (N = 45), and TT (N = 12) in the control group. Patients with the G or T allele included 198 and 42 cases, respectively, in the ACI group. However, subjects with the G or T allele included 171 and 69 cases, respectively, in the control group. APM-1 +276 genotypes and alleles were significantly different between groups (P = 0.041). Thus, the APM-1 +276 SNP but not the APM-1 +45 SNP in the APM-1 gene may be correlated with the incidence of ACI. It have been confirmed that the adiponectin SNP 276G/T genotype is an independent risk factor for stroke and can increase the incidence of stroke (Kawai et al., 2013) .
In this study, only the +45 and +276 polymorphic loci were analyzed to examine the potential relationship between variants and ACI incidence. Previous studies have examined the correlation between other loci in the APM-1 gene and stroke (Liu et al., 2011) . Our future studies will examine the correlation between other loci in the APM-1 gene and stroke, blood pressure, and blood lipids to determine the role and mechanism of the APM-1 gene in regulating blood pressure and lipids in patients with ACI. A large number of epidemiological and experimental studies found that manifestations of genetic characteristics are more obvious in ACI; in addition to environmental factors, genetic factors may play an important role. We found that some loci in the adiponectin gene were associated with ACI, but whether the adiponectin gene is a susceptibility gene for ACI requires further investigation. Therefore, the cloning and identification of the susceptibility gene and locus of ACI can clarify the genetic nature of ACI. This will be useful for detailed clinical classification of ACI, personalized treatment, and prognosis in an early stage, as well as for early screening, prevention, and treatment in individuals carrying the susceptibility gene.
